Sucrose esters with various hydrophilic-lipophilic properties: Novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 3101-3109

  Chansanroj, K ^a   Betz, G ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Controlled release; Direct compaction; HLB value; Matrix tablets; Sucrose esters

Indexed keywords

CALCIUM PHOSPHATE; COMPACTION; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; ESTERS; FATTY ACIDS; GELATION; HYDROGEN BONDS; SUGAR (SUCROSE); TARGETED DRUG DELIVERY; TENSILE STRENGTH;

CONTROLLED RELEASE; DIRECT COMPACTION; DRUG-RELEASE RATE; HYDROPHILIC LIPOPHILIC BALANCE; HYDROPHILIC-LIPOPHILIC BALANCE VALUE; HYDROPHILICS; LIPOPHILIC PROPERTIES; MATRIX TABLET; SUCROSE ESTERS; TABLETING PROPERTIES;

HYDROPHILICITY;

CALCIUM PHOSPHATE DIBASIC; METOPROLOL TARTRATE; SUCROSE ESTER DERIVATIVE; DRUG DERIVATIVE; SUCROSE; SUCROSE STEARATE;

ARTICLE; COMPRESSION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; GELATION; HYDROPHILICITY; LIPOPHILICITY; LUBRICATION; MATRIX TABLET; PLASTICITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TENSILE STRENGTH; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; METHODOLOGY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; POROSITY; STANDARD; TABLET; TRANSITION TEMPERATURE;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; LUBRICATION; PARTICLE SIZE; POROSITY; REFERENCE STANDARDS; SUCROSE; TABLETS; TENSILE STRENGTH; TRANSITION TEMPERATURE;

EID: 77955881660     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.044     Document Type: Article

References (46)

1. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today 2000;3:198-204.
2. ® Sugar Ester Technical Information. Tokyo: Mitsubishi-Kagaku Foods Corporation; 2003.
3. Garti N, Clement V, Leser M, Aserin A, Fanun M. Sucrose ester microemulsions. J Mol Liq 1999;80:253-96.
4. Muller AS, Gagnaire J, Queneau Y, Karaoglanian M, Maitre JP, Bouchu A. Winsor behaviour of sucrose fatty acid esters: choice of the cosurfactant and effect of the surfactant composition. Colloids Surf A: Physicochem Eng Aspects 2002;203:55-66.
5. Shigeoka T, Izawa O, Kitazawa K, Yamauchi F. Studies on the metabolic fate of sucrose esters in rats. Food Chem Toxicol 1984;22:409-14.
6. 14C-labelled sucrose esters of stearic acid in rats. Food Chem Toxicol 1997;35:589-95.
7. Walker CE. Food applications of sucrose esters. Cereal Foods World 1984;29:286-9.
8. Husband FA, Samey DB, Barnard MJ, Wilde PJ. Comparison of foaming and interfacial properties of pure sucrose monolaurates, dilaurate and commercial preparations. Food Hydrocolloids 1998;12:237-44.
9. Tual A, Bourles E, Barey P, Houdoux A, Desprairies M, Courthaudon J-L. Effect of surfactant sucrose ester on physical properties of dairy whipped emulsions in relation to those of O/W interfacial layers. J Colloid Interf Sci 2006;295:495-503.
10. Ntawukulilyayo JD, Bouckaert S, Remon JP. Enhancement of dissolution rate of nifedipine using sucrose ester coprecipitates. Int J Pharm 1993;93:209-14.
11. Yokoi Y, Yonemochi E, Terada K. Effect of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension. Int J Pharm 2005;290:91-9.
12. Ganem-Quintanar A, Quintanar-Guerrero D, Falson-Rieg F, Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int J Pharm 1998;173:203-10. (Pubitemid 29027774)
13. Ahsan F, Arnold JJ, Meezan E, Pillion DJ. Sucrose cocoate, a component of cosmetic preparations, enhances nasal and ocular peptide absorption. Int J Pharm 2003;251:195-203.
14. Csóka G, Marton S, Zelko R, Otomo N, Antal I. Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 2007;65:233-7.
15. El-Laithy HM. Novel transdermal delivery of timolol maleate using sugar esters: Preclinical and clinical studies. EurJ Pharm Biopharm 2009;72:239-45.
16. Ntawukulilyayo JD, Demuynck C, Remon JP. Microcrystalline cellulose-sucrose esters as tablet matrix forming agents. Int J Pharm 1995;121:205-10.
17. Koseki T, Onishi H, Takahashi Y, Uchida M, Machida Y. Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent. Chem Pharm Bull 2008; 56 (10): 1384-8.
18. Aoshima H, Miyagisnima A, Nozawa Y, Sadzuka Y, Sonobe T. Glycerin fatty acid esters as a new lubrication of tablets. Int J Pharm 2005;293:25-34.
19. The Merck Index: An encyclopedia of chemicals, drugs, and biological. 14th edition. NJ: Merck & Co., Inc.; 2006. p 6149.
20. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12(3);413-420.
21. Armstrong NA, Haines-Nutt RF. Elastic recovery and surface area changes in compacted powder systems. Powder Technol 1974;9:287-90.
22. Fell JT, Newton JM. Determination of tablet strength by diametral compression test. J Pharm Sci 1970;59(12);688-691.
23. Heckel R. An analysis of powder compaction phenomena. Trans Metal Soc 1961;221:1001-8.
24. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.
25. Peppas NA. Analysis of fickian and non-fickian release from polymers. Pharm Acta Helv 1985;60:110-1.
26. Lindner WD, Lippold BC. Drug release from hydrocolloid embedding with high or low susceptibility to hydrodynamic stress. Pharm Res 1995; 12 (11): 1781-5.
27. Adolfsson A, Nyström C. Tablet strength, porosity, elasticity and solid state structure of tablets compressed at high loads. Int J Pharm 1996;132:95-106.
28. Vromans H, Lerk CF. Densification properties and compactability of mixtures of pharmaceutical excipients with and without magnesium stearate. Int J Pharm 1988;46:183-92.
29. Ragnarsson G. Force-displacement and network measurement. In: Alderborn G, Nyström C, editors. Pharmaceutical powder compaction technology. New York: Marcel Dekker; 1996. p. 77-97.
30. Ragnarsson G, Sjögren J. Influence of the granulating method on bulk properties and tabletability of a high dosage drug. Int J Pharm 1982;12:163-71.
31. Krycer I, Pope DG, Hersey JA. An evaluation of the techniques employed to investigate powder compaction behaviour. Int J Pharm 1982;12:113-34.
32. Vachon MG, Chulia D. The use of energy indices in estimating powder compaction functionality of mixtures in pharmaceutical tableting. Int J Pharm 1999;177:183-200.
33. Gustafsson C, Bonferoni MC, Caramella C, Lennholm H, Nyström C. Characterisation of particle properties and compaction behaviour of hydroxypropyl methylcellulose with different degrees of methoxy/hydroxypropyl substitution. Eur J Pharm Sci 1999;9:171-84.
34. Van der Voort Maarschalk K, Zurrman K, Vromans H, Bolhuis GK, Lerk CF. Stress relaxation of compacts produced from viscoelastic materials. Int J Pharm 1997;151:27-34.
35. Van der Voort Maarschalk K, Zurrman K, Vromans H, Bolhuis GK, Lerk CF. Porosity expansion of tablets as a result of bonding and deformation of particulate solids. Int J Pharm 1996;140:185-93.
36. Riepma KA, Veenstra J, de Boer AH, Bolhuis GK, Zuurman K, Lerk CF, et al. Consolidation and compaction of powder mixtures: II. Binary mixtures of different particle size fractions of α-lactose monohydrate. Int J Pharm 1991;76:9-15.
37. Garr JSM, Rubinstein MH. The effect of rate of force application on the properties of microcrystalline cellulose and dibasic calcium phosphate mixtures. Int J Pharm 1991;73:75-80.
38. Ilkka J, Paronen P. Prediction of the compression behavior of powder mixtures by the Heckel equation. Int J Pharm 1993;94:181-7.
39. Busignies V, Leclerc B, Porion P, Evesque P, Couarraze G, Tchoreloff P. Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients. Eur J Pharm Biopharm 2006;64:64-74.
40. Hardy IJ, Cook WG, Melia CD. Compression and compaction properties of plasticised high molecular weight hydroxypropylmethylcellulose (HPMC) as a hydrophilic matrix carrier. Int J Pharm 2006;311:26-32.
41. Szuüts A, Pallagi E, Regdon G, Aigner Z, Szabó- Révész P. Study of thermal behaviour of sugar esters. Int J Pharm 2007;336:199-207.
42. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987;5:23-36.
43. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 1987;5:37-42.
44. Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging - effect of solubility of additives on HPMC matrix tablets. Eur J Pharm Sci 2009;37:89-97.
45. Viridén A, Wittgren B, Larsson A. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur J Pharm Sci 2009;36:297-309.
46. Mitchell K, Ford JL, Armstrong DJ, Elliott PNC, Hogan JE, Rostron C. The influence of substitution type on the performance of methylcellulose and hydroxypropylmethylcellulose in gels and matrices. Int J Pharm 1993;100:143-54. (Pubitemid 23316326)